Compare Victoria's Secret & Co (VSXY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Victoria's Secret & Co vs State Street SPDR S&P Biotech ETF — how do they compare? Victoria's Secret & Co trades at $87.75 (market cap $6.95B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Victoria's Secret & Co is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| VSXY | XBI | |
|---|---|---|
Market Cap | $6.95B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $88.50 | $164.28 |
52-Week Low | $18.72 | $85.16 |
Enterprise Value | $9.59B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
